LC with Novel Electrochemical Detection for Analysis of Monoamine Neurotransmitters in Rat Brain After Administration of (R)-Salsolinol and (R)-N-Methylsalsolinol

A novel electrochemical detector with an acetylcholine film has been developed for HPLC. The chemically modified electrode is an efficient electrocatalyst of (R)-salsolinol ((R)-Sal), (R)-N-methylsalsolinol ((R)-NMSal), and monoamine neurotransmitters, enabling highly sensitive detection. The electrode is also stable and long-lived. Combined with microdialysis sampling, HPLC with the novel detector enabled successful study of changes in the concentrations of monoamine neurotransmitters in rat brain after the injection of (R)-salsolinol and (R)-N-methylsalsolinol.

[1]  H. Tohgi,et al.  An endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the cerebrospinal fluid decreases with progression of Parkinson's disease , 1999, Neuroscience Letters.

[2]  M. Naoi,et al.  Salsolinol is a Putative Endogenous Neuro‐intermediate Lobe Prolactin‐Releasing Factor , 2001, Journal of neuroendocrinology.

[3]  Jun Ren,et al.  Insulin-like growth factor-1 protects human dopaminergic SH-SY5Y cells from Salsolinol-induced toxicity , 2003, Neuroscience Letters.

[4]  M. Naoi,et al.  A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains , 1997, Neuroscience Letters.

[5]  F. Musshoff,et al.  Determination of dopamine and dopamine-derived (R)-/(S)-salsolinol and norsalsolinol in various human brain areas using solid-phase extraction and gas chromatography/mass spectrometry. , 2000, Forensic science international.

[6]  R. Coccia,et al.  Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells. , 2002, Biochemical pharmacology.

[7]  J. Sweedler,et al.  Determination of salsolinol enantiomers by gas chromatography-mass spectrometry with cyclodextrin chiral columns , 2000 .

[8]  Xiangqin Lin,et al.  Novel choline and acetylcholine modified glassy carbon electrodes for simultaneous determination of dopamine, serotonin and ascorbic acid , 2004 .

[9]  Jian Wang,et al.  Amperometric determination of (R)-salsolinol, (R)-N-methylsalsolinol and monoamine neurotransmitters with liquid chromatography using functionalized multi-wall carbon nanotube modified electrode in Parkinson's patients' cerebrospinal fluid , 2004 .

[10]  Y. Surh,et al.  IRON ENHANCEMENT OF OXIDATIVE DNA DAMAGE AND NEURONAL CELL DEATH INDUCED BY SALSOLINOL , 2002, Journal of toxicology and environmental health. Part A.

[11]  B. Renaud,et al.  Capillary zone electrophoresis with laser-induced fluorescence detection for the determination of nanomolar concentrations of noradrenaline and dopamine: application to brain microdialysate analysis. , 1995, Analytical chemistry.

[12]  P. Riederer,et al.  N-methyl-(R)-salsolinol and its relevance to Parkinson's disease , 1998, The Lancet.

[13]  Y. Akao,et al.  Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease. , 2002, Neurotoxicology and teratology.

[14]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[15]  Fa Zhang.  Formation of novel toxic compounds from oxidative interaction between salsolinol and cysteine. , 2002, Journal of pharmaceutical and biomedical analysis.

[16]  M. Naoi,et al.  Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells. , 2004, Life sciences.

[17]  M. Naoi,et al.  Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. , 2004, Neurotoxicology.

[18]  Johannes Schwarz,et al.  1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism , 2000, Brain Research.

[19]  M. Naoi,et al.  A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol , 1996, Neuroscience Letters.

[20]  M. Naoi,et al.  Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies , 1996, Brain Research.

[21]  Brij B. Singh,et al.  TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis , 2006, Brain Research.

[22]  T. Nakazato,et al.  High-speed voltammetry: dual measurement of dopamine and serotonin , 1999, Journal of Neuroscience Methods.

[23]  Yulin Deng,et al.  Assay for the (R)- and (S)-enantiomers of salsolinols in biological samples and foods with ion-pair high-performance liquid chromatography using beta-cyclodextrin as a chiral mobile phase additive. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[24]  A. Szczudlik,et al.  Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology , 1997, Biological Psychiatry.

[25]  M. Naoi,et al.  (R) salsolinol N‐methyltransferase activity increases in parkinsonian lymphocytes , 1998, Annals of neurology.

[26]  H. Przuntek,et al.  R- and S-salsolinol are not increased in cerebrospinal fluid of Parkinsonian patients , 1999, Journal of the Neurological Sciences.

[27]  A. Shirahata,et al.  Fluorometric determination of 1,2,3,4-tetrahydro-6,7-dihydroxyisoquinoline in biological materials by HPLC. , 1997, Chemical & pharmaceutical bulletin.

[28]  A. Szczudlik,et al.  Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain , 2000, Neuroscience.

[29]  F. Musshoff,et al.  A systematic regional study of dopamine and dopamine-derived salsolinol and norsalsolinol levels in human brain areas. , 1999, Forensic science international.

[30]  R. Odom,et al.  Matrix-enhanced secondary ion mass spectrometry:  a method for molecular analysis of solid surfaces. , 1996, Analytical chemistry.